Cathepsin Inhibition Induces Apoptotic Death in Human Leukemia and Lymphoma Cells

References

• Kos J, Lah T T. Cysteine proteinase and their endogenous inhibitors: Target proteins for prognosis, diagnosis and therapy in cancer (Review). Oncol Rep 1998; 5: 1349–1361
   PubMed Web of Science ®Google Scholar
• Yan S, Sameni M., Sloane B F. Cathepsin B and human tumor progression. Biol Chem 1998; 379: 113–123
   PubMed Web of Science ®Google Scholar
• Rooprai H K, McCormick D. Proteases and their inhibitors in human brain tumors: a review. Anticancer Res 1997; 17: 4151–4162
   PubMed Web of Science ®Google Scholar
• Heidtmann H H, Salge U, Abrahamson M, Bencina M, Kastalie L, Kopitar-Jerala N, Turk V, Lah T T. Cathepsin B and cysteine protease inhibitors in human lung caner cell lines. Clin Exp Metastasis 1997; 15: 368–381
   PubMed Web of Science ®Google Scholar
• Keppler D, Sameni M, Moin Mikkelsen K., Diglio T. C., Sloane B. Tumor progression and angiogenesis: cathepsin B & Co. Biochem Cell Biol 1996; 74: 799–810
   PubMed Web of Science ®Google Scholar
• Duffy M J. The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 1992; 10: 145–155
   PubMed Web of Science ®Google Scholar
• Demuth H U, Schierhorn A, Bryan P, Hofke R, Kirschke H, Bromine D. N-peptidyl, O-acyl hydroxamates: comparison of the selective inhibition of serine and cysteine proteinases. Biochim Biophys Acta 1996; 1295: 179–186
   PubMed Web of Science ®Google Scholar
• Uckun F M, Waddick K G, Mahajan S, Xiao J, Takata M, Bolen J, Kurosaki T. BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science 1996; 273: 1096–1100
   PubMed Web of Science ®Google Scholar
• Zhu D, Fang M., W-Narla H. R-K., Uckun F M. A requirement for protein kinase C inhibition for calcium-trigered apoptosis in Acute lymphoblastic leukemia cells. Clin Can Res 1999; 5: 355–360
   PubMed Web of Science ®Google Scholar
• Lowe S W., Ruley H E, Jacks T, Housman D E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993a; 71: 957–967
   Web of Science ®Google Scholar
• Lowe S, Schmitt W. EM., Smith S W, Osborne B A, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993b; 362: 847–849
   PubMed Web of Science ®Google Scholar
• Peller S. Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response. Cancer Biol. 1998; 8: 370–387
   Web of Science ®Google Scholar
• Blandino G B, Levine A, Oren J. M. Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy. Oncogene 1999; 18: 477–485
   PubMed Web of Science ®Google Scholar
• Doman R K, Perez M, Donato N J. JNK and p53 stress signaling cascades are altered in MCF-7 cells resistant to tumor necrosis factor-mediated apoptosis. J Interferon Cytokine Res 1999; 19: 261–269
   PubMed Web of Science ®Google Scholar
• Cordone I, Masi S, Mauro F R, Soddu S, Morsilli O, Valentini T, Vegna M L, Guglielmi C, Mancini F, Giuliacci S, Sacchi A, Mandelli F, Foa R. p53 expression in B-cell chronic lymphocytie leukemia: a marker of disease progression and poor prognosis. Blood 1998; 91: 4342–4349
   PubMed Web of Science ®Google Scholar
• Gutiérrez M I, Cherney B, Hussain A, Mostowski H, Tosato G, Magrath I, Bhatia K. Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis. Cancer Res 1999; 59: 696–703
   PubMed Web of Science ®Google Scholar
• Meijerink J P, Mensink E J, Wang K, Sedlak T W, Sloetjes A W, de Write T, Waksman G, Korsmeyer S J. Hematopoietic malignancies demonstrate loss-of-function mutations of BAX. Blood 1998; 91: 2991–2997
   PubMed Web of Science ®Google Scholar
• Brimmell M, Mendiola R, Mangion J, Packham G. BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 1998; 16: 1803–1812
   PubMed Web of Science ®Google Scholar
• Slee E A, Zhu H, Chow S C, MacFarlane M, Nicholson D W, Cohen G M. Benzyloxycarbonyl-Val-Ala-Asp (Ome) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J 1996; 315: 21–24
   PubMed Web of Science ®Google Scholar
• Chow S C, Weiss M, Kass G E, Holmstrom T H, Eriksson J E, Orrenius S. Involvement of multiple proteases during Fas-mediated apoptosis in T lymphocytes. FEBS Lett 1995; 364: 134–38
   PubMed Web of Science ®Google Scholar
• Fearnhead H O, Dinsdale D, Cohen G M. An interleukin-I beta-converting enzyme-like protease is a common mediator of apoptosis in thymocytes. FEBS Left 1995; 375: 283–288
   PubMed Web of Science ®Google Scholar
• Pronk G J, Ramer K, Amiri P, Williams L T. Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 1996; 271: 808–810
   PubMed Web of Science ®Google Scholar
• Garcia-Calvo M, Peterson E, Leiting P. B., Ruel Nicholson R. DW., Thornberry N A. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 1998; 273: 32608–32613
   PubMed Web of Science ®Google Scholar
• Zuo H, Henzel W J, Liu X, Lutschg Wang A. Apaf-I. a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of eas-pase-3. Cell 1997; 90: 405–413
   PubMed Web of Science ®Google Scholar
• Li Nijhawan P., Budihardjo D. I., Srinivasula S M, Ahmad M, Alnemri E, Wang X. Cytochrome c and dATP-dependent formation of Apaf-l/caspasc-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479–489
   PubMed Web of Science ®Google Scholar
• Schlegel J, Peters I, Orrenius S, Miller D K, Thormberry N A, Yamin T T, Nicholson D W. CPP32/apopain is a key interleukin 1 deta converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem 1996; 271: 1841–1844
   PubMed Web of Science ®Google Scholar
• Thornberry N A, Lazebnik Y. Caspases: enemies within. Science 1998; 281: 1312–1316
   PubMed Web of Science ®Google Scholar
• Green D R, Reed J C. Mitochondria and apoptosis. Science 1998; 281: 1309–1312
   PubMed Web of Science ®Google Scholar
• Henkart P A. ICE family protease: mediators of all apoptotic death?. Immunity 1996; 4: 195–201
   PubMed Web of Science ®Google Scholar
• Magi-Galluzzi C, Montironi R, Cangi M G, Wishnow K, Loda M. Mitogen-activated protein kinases and apoptosis in PIN. Virchows Arch 1998; 432: 407–413
   PubMed Web of Science ®Google Scholar
• Xia Z, Dickens M, Raingeaud J, Davis R J, Greenberg M E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326–1331
   PubMed Web of Science ®Google Scholar